Home
|
Contact Us
|
Careers
Clinical Trials
Business
Investor Center
News Archive
Board of Directors
Management Team
Corporate Governance
Careers
SEC Filings
Science
Therapeutic Pathways
MKC-1
ENMD-1198
ENMD-2076
Panzem
®
Tubulin Inhibitors
HDAC Inhibitors
Scientific Advisory Board
Science Archive
Science
Therapeutic Pathways
MKC-1
ENMD-1198
ENMD-2076
Panzem
®
Tubulin Inhibitors
HDAC Inhibitors
Scientific Advisory Board
Science Archive
Science Archive
Browse EntreMed’s scientific posters, presentations and publications.
Wednesday, April 16, 2008 -
EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
View the posters
,
Read the press release
Monday, April 14, 2008 -
EntreMed's Kinase Inhibitor, ENMD-2076, Presented During AACR Special Session
Download the presentation as a PDF
View the webcast
,
Read the press release
Monday, January 28, 2008 -
EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study
View the poster
,
Read the press release
Monday, December 10, 2007 -
EntreMed Presents Results for ENMD-1198 and Vincristine in Preclinical Leukemia Models
View the poster
,
Read the press release
Monday, December 10, 2007 -
EntreMed Presents Results for Its Lead Aurora Kinase-Angiogenesis Inhibitor
View the poster
,
Read the press release
Thursday, October 25, 2007 -
EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
View the poster
,
Read the press release
Thursday, October 25, 2007 -
EntreMed Shows Increased Survival with MKC-1 in Preclinical Renal Cell Cancer Model
View the poster
,
Read the press release
Wednesday, October 24, 2007 -
EntreMed Presents Results for Panzem® NCD Phase 2 Ovarian Cancer Study
View the poster
,
Read the press release
Monday, September 10, 2007 - Poster
EntreMed Presents Data for Phase 2 Studies of MKC-1 in Metastatic Breast Cancer
View the poster
,
Read the press release
Thursday, August 9, 2007 - Presentation
EntreMed to Present at IBCs 12th Annual Drug Discovery Conference
View the presentation
,
Read the press release